Page last updated: 2024-10-29

ketamine and Conus Medullaris Syndrome

ketamine has been researched along with Conus Medullaris Syndrome in 3 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheng, HW1
Lam, KO1
Li, CW1
Chan, KY1
Sham, MK1
Siegal, T4
Shohami, E1
Lossos, F2

Other Studies

3 other studies available for ketamine and Conus Medullaris Syndrome

ArticleYear
Successful Analgesic use of Ketamine Infusion in Malignant Cord Compression.
    Pain medicine (Malden, Mass.), 2015, Volume: 16, Issue:10

    Topics: Analgesics; Female; Humans; Infusions, Intravenous; Ketamine; Middle Aged; Neuralgia; Spinal Cord Co

2015
Experimental neoplastic spinal cord compression: effect of ketamine and MK-801 on edema and prostaglandins.
    Neurosurgery, 1990, Volume: 26, Issue:6

    Topics: Analysis of Variance; Animals; Brain Edema; Dibenzocycloheptenes; Dizocilpine Maleate; Edema; Histio

1990
Experimental neoplastic spinal cord compression: effect of anti-inflammatory agents and glutamate receptor antagonists on vascular permeability.
    Neurosurgery, 1990, Volume: 26, Issue:6

    Topics: Animals; Anti-Inflammatory Agents; Capillary Permeability; Dexamethasone; Dibenzocycloheptenes; Dizo

1990